Diabetes & Metabolic Diseases
This track highlights advanced biological solutions targeting pancreatic beta-cell dysfunction and chronic insulin resistance. Topics include islet cell transplantation, endocrine differentiation, and glucose-responsive systems. Endocrinologists at Stem Cells 2027 will analyze long-term glycemic stabilization outcomes. Attendees will master pancreatic islet regeneration and novel metabolic cell therapies to replace traditional insulin dependence.